Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-29

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental ANDA for Metformin Hydrochloride from Aurobindo Pharma Limited, authorizing the generic product's market entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)